CurrentEndo coverage · page 24 of 33

Cardiovascular Diabetology

Briefs 921–960 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol6 Mar 2024
Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
Diagnostic or prognostic studyT2D & other
Cardiovasc Diabetol6 Mar 2024
The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study
Cross-sectional studyT2D & other
Cardiovasc Diabetol2 Mar 2024
Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis : Platelets in cardiovascular risk
Cross-sectional studyT2D & other
Cardiovasc Diabetol28 Feb 2024
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study
Cohort studyT1D
Cardiovasc Diabetol28 Feb 2024
The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
Cohort studyT2D & other
Cardiovasc Diabetol28 Feb 2024
Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study
Cohort study
Cardiovasc Diabetol28 Feb 2024
Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study
Cohort study
Cardiovasc Diabetol24 Feb 2024
Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study
Secondary analysisT2D & other
Cardiovasc Diabetol24 Feb 2024
Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
Meta-analysisT2D & other
Cardiovasc Diabetol24 Feb 2024
Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study
Cohort studyT2D & other
Cardiovasc Diabetol24 Feb 2024
Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study
Cohort studyT2D & other
Cardiovasc Diabetol24 Feb 2024
Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study
Cross-sectional study
Cardiovasc Diabetol24 Feb 2024
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study
Cohort study
Cardiovasc Diabetol20 Feb 2024
The association between the AIP and undiagnosed diabetes in ACS patients with different body mass indexes and LDL-C levels: findings from the CCC-ACS project
Cross-sectional studyT2D & other
Cardiovasc Diabetol20 Feb 2024
Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states
Cross-sectional studyT2D & other
Cardiovasc Diabetol16 Feb 2024
Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study
Cohort study
Cardiovasc Diabetol15 Feb 2024
The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis
Meta-analysisT2D & other
Cardiovasc Diabetol15 Feb 2024
Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
Cohort studyT2D & other
Cardiovasc Diabetol15 Feb 2024
Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
Meta-analysisT2D & other
Cardiovasc Diabetol13 Feb 2024
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
Cross-sectional studyT2D & other
Cardiovasc Diabetol13 Feb 2024
Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction
Cohort studyComplications
Cardiovasc Diabetol13 Feb 2024
DNA methylation risk score for type 2 diabetes is associated with gestational diabetes
Cohort studyDiabetes in pregnancy
Cardiovasc Diabetol12 Feb 2024
Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults
Cohort studyLipids & liver
Cardiovasc Diabetol10 Feb 2024
The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database
Cohort study
Cardiovasc Diabetol10 Feb 2024
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program
Secondary analysisT2D & other
Cardiovasc Diabetol9 Feb 2024
Circulating exosomal mir-16-2-3p is associated with coronary microvascular dysfunction in diabetes through regulating the fatty acid degradation of endothelial cells
Mechanistic studyT2D & other
Cardiovasc Diabetol9 Feb 2024
Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database
Cohort studyT2D & other
Cardiovasc Diabetol9 Feb 2024
Relationship between stress hyperglycaemic ratio and incidence of in-hospital cardiac arrest in patients with acute coronary syndrome: a retrospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol8 Feb 2024
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
Cohort studyT2D & other
Cardiovasc Diabetol8 Feb 2024
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study
Randomized controlled trialT2D & other
Cardiovasc Diabetol8 Feb 2024
The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode
Randomized controlled trialT1D
Cardiovasc Diabetol8 Feb 2024
Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism
Cohort studyT2D & other
Cardiovasc Diabetol3 Feb 2024
Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry
Secondary analysisT2D & other
Cardiovasc Diabetol3 Feb 2024
Association of plasma proteomics with incident coronary heart disease in individuals with and without type 2 diabetes: results from the population-based KORA study
Cohort studyT2D & other
Cardiovasc Diabetol3 Feb 2024
Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors—a mendelian randomization analysis
Research articleLipids & liver
Cardiovasc Diabetol1 Feb 2024
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
Cross-sectional studyT2D & other
Cardiovasc Diabetol1 Feb 2024
Gestational diabetes mellitus and risk of long-term all-cause and cardiac mortality: a prospective cohort study
Cohort studyDiabetes in pregnancy
Cardiovasc Diabetol1 Feb 2024
The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol28 Jan 2024
Association of temporal change in body mass index with sudden cardiac arrest in diabetes mellitus
Cohort studyT2D & other
Cardiovasc Diabetol28 Jan 2024
Independent association of thigh muscle fat density with vascular events in Korean adults
Cohort study

All 1,291 Briefs in ExploreShowing Briefs 921–960 of 1,291, newest first